团队成员

艾乐达先生是具有以色列空军20年资历的老将，担任过许多高阶技术性职务，包括卫星计划的领导。后来他也成为卫星通信公司SpaceCom（以色列股市代号：SCC）的工程副总，于2012年他才与伙伴共同创立了CardiacSence公司。

Eitan is Co-CEO of CardiacSense, advancing vital-sign monitoring including blood pressure, ECG, and arrhythmia detection. Previously, he served as CEO of Road2 and held senior roles at Kamada, PolyPid, Biosense Webster (Johnson & Johnson), and Lumenis. He began his career as a commercial lawyer, specializing in hi-tech and life-science transactions. For 15 years, he has led Friendly Angels Club. Eitan holds an LL.B. and an MBA from Haifa University

在加入CardiacSense之前，丽雅特曾服务于多家高科技新创公司，从中她获取了广泛深厚的经验，包括在项目管理、贝塔测试、产品验证和领导技术团队等方面。

Head of Hardware at CardiacSense for the past nine years, with over 25 years of high-tech industry experience. Holds a B.Sc. in Electrical and Computer Engineering from Ben-Gurion University. Leads end-to-end hardware development, combining deep technical expertise with product-minded execution and strong cross-functional leadership.

萨米教授是特拉维夫大学索拉斯基医学中心（又名“伊西洛夫”）的心脏科住院部主任，及特拉维夫大学心脏病学的副教授。他是一名多产的医学刊物编辑，在同侪审查的医学期刊中有170篇报告都归诸于他的贡献。

雅各教授是特拉维夫大学索拉斯基医学中心（又名“伊西洛夫”）的内科F部主任及自主性研究中心主任。他同时也是特拉维夫大学医学院医药与生理学教授。他的研究领域包括心血管系统在健康与疾病上的法规机制、自主神经系统、脑部血流及凝固作用等。

过去20年来，艾亚勒的专业经验集中在横跨商务和科技的多重领域上，包括卫星、数据存储、带宽优化等。由于其敏锐的分析技能、长远眼光和规划的专精，使得他能创造管理工作上的卓越成就。

BS and MBA, Cornell University. Former President of the Cardiology business, Boston Scientific, inducted into Minnesota Business Hall of Fame. Mr. Berman brings over 30 years of experience as Medical device investor/entrepreneur and currently serving on the boards of 10 emerging medical companies.

达尼尔过去35年来的事业重心主要在战略、创新和科技方面。他曾于美国担任百事公司的高级副总和总经理，先前也曾是麦肯锡在欧洲和美国的合伙人。

波利斯是以色列理工大学电机工程学院的高级科学家和讲师，他拥有新西伯利亚市俄罗斯科学院西伯利亚分院的光学博士学位。他的专业经历超过35年，领导过20件以上电光学方面的重大项目。

Over 20 years of experience leading multinational clinical trials across pharma, biotech, and start-ups. Extensive expertise in end-to-end clinical trial design and management in complex global programs. Her extensive background spans leadership positions across pharmaceutical companies, biotech and start-ups.